NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 46 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,003,780 | +0.9% | 34,882 | +1.9% | 0.01% | -16.7% |
| Q1 2023 | $2,977,574 | -4.0% | 34,244 | -1.9% | 0.01% | -14.3% |
| Q4 2022 | $3,100,727 | +3.5% | 34,890 | +4.2% | 0.01% | -6.7% |
| Q3 2022 | $2,995,000 | -19.9% | 33,489 | -20.9% | 0.02% | -11.8% |
| Q2 2022 | $3,740,000 | +14.3% | 42,358 | +18.6% | 0.02% | +30.8% |
| Q1 2022 | $3,271,000 | -2.2% | 35,700 | 0.0% | 0.01% | +8.3% |
| Q4 2021 | $3,345,000 | – | 35,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 134,334,000 | $116,802,148 | 3.85% |
| STEELHEAD PARTNERS LLC | 46,562,000 | $40,485,659 | 2.64% |
| DeepCurrents Investment Group LLC | 40,000,000 | $34,578,496 | 1.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 76,557,000 | $66,300,852 | 0.78% |
| SHENKMAN CAPITAL MANAGEMENT INC | 11,317,000 | $9,786,521 | 0.74% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,856,000 | $4,199,900 | 0.62% |
| Ionic Capital Management LLC | 2,000,000 | $1,726,349 | 0.50% |
| Empyrean Capital Partners, LP | 15,000,000 | $12,980,000 | 0.44% |
| Context Capital Management, LLC | 4,489 | $3,903 | 0.33% |
| Graham Capital Management, L.P. | 11,422,000 | $9,875,746 | 0.30% |